United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

16 Nov 2018
Change (% chg)

Rs4.65 (+0.90%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)


Beta: 0.27
Market Cap(Mil.): Rs1,347,823.00
Shares Outstanding(Mil.): 2,399.33
Dividend: 2.00
Yield (%): 0.36


  SUN.BO Industry Sector
P/E (TTM): 50.06 28.12 29.34
EPS (TTM): 11.22 -- --
ROI: 7.69 14.10 13.58
ROE: 6.91 15.67 15.11

UPDATE 1-Indian drugmaker Sun Pharma swings to surprise quarterly loss

Nov 13 Sun Pharmaceutical Industries was sent to an unexpected second-quarter loss by a one-off charge for an antitrust litigation settlement.

Nov 13 2018

India's Sun Pharma posts surprise quarterly loss on one-time charge

Nov 13 Sun Pharmaceutical Industries Ltd , India's largest drugmaker by market capitalisation, posted a surprise quarterly loss on Tuesday, hurt by a one-time charge due to a legal settlement.

Nov 13 2018

Morning News Call - India, August 16

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_08162018.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 11:30 am: Banking Secretary Rajiv Kumar at launch of Canara Bank’s digital branch in New Delhi. LIVECHAT - BONDS UPDATE Reuters interest rate reporter Dhara Ranasinghe delves into gove

Aug 15 2018

UPDATE 1-India's Sun Pharma Q1 profit beats estimates as U.S. sales climb

* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)

Aug 14 2018

India's Sun Pharma quarterly profit beats estimates

Aug 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates.

Aug 14 2018

India's Sun Pharma says U.S. FDA clears Halol plant

MUMBAI, June 12 India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) cleared its Halol drug plant, which had been under supply restrictions due to quality control failures.

Jun 12 2018

Indian shares end higher; banks, oil firms gain

May 28 Indian shares ended higher for a third session on Monday, as lower crude prices and a firmer rupee lifted sentiment, with financial and oil stocks accounting for much of the gains.

May 28 2018

Indian shares gain as crude oil slips; Sun Pharma top gainer

May 28 Indian equities gained for a third straight session on Monday as a sharp drop in crude prices and a recovery in the rupee boosted sentiment, while shares of Sun Pharmaceutical Industries saw their best day in over three years on strong fourth-quarter results.

May 28 2018

UPDATE 2-India's Sun Pharma warns U.S. pricing pressure to hit 2019 profit

* Plans to reduce "unviable" generics research (Adds managing director comments from conference call)

May 25 2018

India's Sun Pharma Industries Q4 profit up 7 pct, beats estimates

May 25 Sun Pharmaceutical Industries Ltd , India's largest drugmaker, posted fourth-quarter net profit way above expectations.

May 25 2018

Earnings vs. Estimates